FMA Advisory’s Core Laboratories CLB Stock Holding History

FMA Advisory’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$11K	Buy	+100	New	+$12.1K	0.01%	276

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

FMA Advisory's CLB Position: Q2 2015 in Review

FMA Advisory opened a new position in Core Laboratories (CLB) in Q2 2015: 100 shares worth $11K. The stake represents 0.01% of the portfolio and ranks #276 among its holdings.

356 funds tracked by Wall St. Rank hold CLB as of Q2 2015.

FMA Advisory held 100 shares of Core Laboratories worth $11K as of Q2 2015.
Core Laboratories was a new FMA Advisory position in Q2 2015.
Core Laboratories made up 0.01% of FMA Advisory's portfolio in Q2 2015, its #276 holding.
356 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2015.

Based on FMA Advisory's 13F filing for Q2 2015, filed 17 Dec 2019.